Neuroendocrine immune responses to inflammation: the concept of the neuroendocrine immune loop

Aird, 1993, Corticotropin-releasing factor mRNA in rat thymus and spleen, 90, 7104 Akira, 1990, Biology of multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF), FASEB Journal, 4, 2860, 10.1096/fasebj.4.11.2199284 Al-Damuluji, 1985, Adrenergic and opiod control of ACTH secretion in man, Neuroscience Letters, 22, S406 Amstad, 1992, Mechanisms of c-fos induction by active oxygen, Cancer Research, 52, 3952 Angioni, 1993, Corticotropin-releasing hormone modulates cytokines release in cultured human peripheral blood mononuclear cells, Life Sciences, 53, 1735, 10.1016/0024-3205(93)90160-5 Arend, 1991, Interleukin-1 receptor antagonist. A new member of the interleukin-1 family, Journal of Clinical Investigation, 88, 1445, 10.1172/JCI115453 Baeurle, 1991, The physiology of the NFkB transcription factor, 423 Bagglioni, 1989, Neutrophil activating peptide/IL-8, a novel cytokine that activates neutrophils, Journal of Clinical Investigations, 84, 1045, 10.1172/JCI114265 Baumann, 1990, The regulation of hepatic acute phase plasma genes by hepatocyte stimulating factors and other mediators of inflammation, Molecular Biology and Medicine, 7, 147 Beckman, 1993, Pathological implications of NO, superoxide and peroxynitrite formation, Biochemical Society Transactions, 21, 330, 10.1042/bst0210330 Berci, 1993, Prolactin, pregnancy and autoimmune disease, Journal of Rheumatology, 20, 1095 Bernardini, 1990, Interactions between tumor necrosis factor-α, hypothalamic corticotropin-releasing hormone, and adrenocorticotropin secretion in the rat, Endocrinology, 126, 2876, 10.1210/endo-126-6-2876 Bevan, 1991, IL-1 receptor antagonist regulation of acute phase protein synthesis in human hepatoma cells, Journal of Immunology, 147, 2574, 10.4049/jimmunol.147.8.2574 Blalock, 1985, Proopiomelanocortin-derived peptides in the immune system, Clinical Endocrinology, 22, 823, 10.1111/j.1365-2265.1985.tb00173.x Blatteis, 1988, Neural mechanisms in the pyrogenic and acute-phase responses to interleukin-1, International Journal of Neuroscience, 38, 223, 10.3109/00207458809000500 Blatteis, 1994, Neuromodulation of fever: a possible role for substance P, Annals of the New York Academy of Science, 741, 162, 10.1111/j.1749-6632.1994.tb23097.x Brain, 1988, SP regulates vasodilator activity of calcitonin gene-related peptide, Nature, 335, 73, 10.1038/335073a0 Carr, 1982, Endotoxin-stimulated opioid peptide secretion: two secretory pools and feedback control in vivo, Science, 217, 845, 10.1126/science.6285473 Carter, 1990, Purification, cloning, expression and biological activity of an interleukin-1 receptor antagonist, Nature, 344, 633, 10.1038/344633a0 Cash, 1992, Pituitary-adrenal axis responsiveness to ovine corticotropin releasing hormone in patients with rheumatoid arthritis treated with low dose prednisone, Journal of Rheumatology, 19, 1692 Catania, 1993, αMSH in the modulation of host reactions, Endocrine Reviews, 14, 564 Catania, 1994, Cytokine antagonists in infectious and inflammatory disorders, Annals of the New York Academy of Science, 741, 149, 10.1111/j.1749-6632.1994.tb39655.x Chikanza, 1995, Hypothalmic-pituitary adrenal effects of non-steroidal anti-inflammatory drugs, Arthritis and Rheumatism, 38, 723, 10.1002/art.1780380529 Chikanza, 1991, Hypothalamic-pituitary mediated modulation of immune function: prolactin is a neuroimmune peptide, British Journal of Rheumatology, 30, 203, 10.1093/rheumatology/30.3.203 Chikanza, 1993, The effects of hydrocortisone on in vitro lymphocyte proliferation, IL-2 and IL-4 production in corticosteroid sensitive and resistant subjects, European Journal of Clinical Investigations, 23, 845, 10.1111/j.1365-2362.1993.tb00740.x Chikanza, 1992, Enumeration of interleukin-1 alpha and beta producing cells by flow cytometry, Journal of Immunological Methods, 154, 173, 10.1016/0022-1759(92)90189-Z Chikanza, 1992, Defective hypothalamic response to immune and inflammatory stimuli in patients with rheumatoid arthritis, Arthritis and Rheumatism, 35, 1281, 10.1002/art.1780351107 Chikanza, 1993, Excessive and dysregulated secretion of prolactin in rheumatoid arthritis. Immunopathogenetic and therapeutic implications, British Journal of Rheumatology, 32, 445, 10.1093/rheumatology/32.6.445 Chikanza, 1993, TNF soluble receptors (TNF inhibitors) behave as acute phase proteins following major surgery in patients with rheumatoid arthritis, osteomyelitis and osteoarthritis, Clinical Experimental Immunology, 92, 19, 10.1111/j.1365-2249.1993.tb05941.x Chikanza, 1995, Arginine vasopressin secretion in rheumatoid arthritis: pathophysiological implications, Arthritis and Rheumatism, 38, S216 Clevenger, 1990, Interleukin-2 driven nuclear translocation of prolactin in cloned T-lymphocytes, Endocrinology, 127, 3157, 10.1210/endo-127-6-3151 Colotta, 1993, Interleukin-1 type receptor: A decoy target for IL-1 that is regulated by IL-4, Science, 261, 472, 10.1126/science.8332913 Conlon, 1987, Localization of human mononuclear cell interleukin-1, Journal of Immunology, 139, 98, 10.4049/jimmunol.139.1.98 Costa, 1993, Nitric oxide modulates the release of corticotropin releasing hormone from the rat hypothalamus, Brain Research, 605, 187, 10.1016/0006-8993(93)91739-F Crofford, 1993, Corticotropin-releasing hormone in synovial fluids and tissues of patients with rheumatoid arthritis and osteoarthritis, Journal of Immunology, 151, 1587, 10.4049/jimmunol.151.3.1587 Cutolo, 1995, The role of androgens in the pathophysiology of rheumatoid arthritis, Fundamental and Clinical Immunology, 3, 9 Daynes, 1989, Contrasting effects of glucocorticoids on the capacity of T cells to produce growth factors interleukin-2 and interleukin-4, European Journal of Immunology, 19, 2319, 10.1002/eji.1830191221 Delitala, 1983, Differential effects of opiate peptides and alkaloids on anterior pituitary hormone secretion, Neuroendocrinology, 37, 275, 10.1159/000123558 Diamond, 1990, Transcription factor interactions: selectors of positive or negative regulation from single DNA element, Science, 249, 1265, 10.1126/science.2119054 Dinarello, 1991, Interleukin-1 and antagonism, Blood, 77, 641, 10.1182/blood.V77.8.1627.1627 Donnerer, 1992, Increased content and transport of substance P and calcitonin gene-related peptide in sensory nerves innervating inflamed tissue: evidence for a regulatory function of nerve growth factor in vivo, Neuroscience, 49, 693, 10.1016/0306-4522(92)90237-V Edmonds, 1993, An imaginative approach to synovitis—the role of hypoxic reperfusion damage in arthritis, Journal of Rheumatology, 20, 26 Ekman, 1993, Biosynthesis of corticotropin-releasing hormone in human T-lymphocytes, Journal of Neuroimmunology, 44, 7, 10.1016/0165-5728(93)90262-W Elands, 1990, Neurohypophyseal hormone receptors in the rat thymus, spleen and lymphocytes, Endocrinology, 126, 2703, 10.1210/endo-126-5-2703 Engelmann, 1990, Two tumor necrosis factor binding proteins purified from human urine—evidence for immunological cross-reactivity with cell surface tumour necrosis receptors, Journal of Biological Chemistry, 265, 1531, 10.1016/S0021-9258(19)40049-5 Faria, 1990, Inhibition of CRH-41 release by substance P, but not substance K, from the rat hypothalamus in vitro, Brain Research, 538, 76, 10.1016/0006-8993(91)90378-9 Fischer, 1990, Interleukin-1 receptor antagonist circulates in experimental inflammation and human disease, Blood, 79, 2192 Fitzpatrick, 1992, Glucocorticoids in the non-obese (NOD) mouse: basal serum levels, effect of endocrine manipulation and immobilization stress, Life Science, 50, 1063, 10.1016/0024-3205(92)90102-U Friedl, 1989, Mediator-induced activation of xanthine oxidase in endothelial cells, FASEB Journal, 3, 2512, 10.1096/fasebj.3.13.2806779 Gaillard, 1990, Tumor necrosis factor inhibits the hormonal response of the pituitary gland to hypothalamic releasing factors, Endocrinology, 127, 101, 10.1210/endo-127-1-101 German, 1993, Interleukin-12/T cell stimulating factor, a cytokine with multiple effects on Th1 but not Th2 cells, European Journal of Immunology, 23, 1762, 10.1002/eji.1830230805 Grossman, 1993, The regulation of hypothalamic FRH. Impact of in vitro studies on the central control of the stress response, Functional Neurology, 8, 325 Hadzhikostova, 1979, Changes of ACTH, STH, TSH and prolactin levels in endotoxic shock in rats, Agressologie, 20, 203 Hammond, 1991, An amino acid substitution in BioBreeding rat corticosteroid binding globulin results in reduced steroid binding affinity, Journal of Biology and Chemistry, 266, 18555, 10.1016/S0021-9258(18)55098-5 Hanamaijer, 1993, Regulation of metalloproteinase expression in human vein and microvascular endothelial cells, Biochemistry Journal, 296, 803, 10.1042/bj2960803 Harbuz, 1993, Changes in hypothalamic corticotrophin releaseing factor and pituitary POMC mRNA during the course of experimental allergic encephalomyelitis, Journal of Neurendocrinology, 45, 127 Hartung, 1988, Substance P: binding properties and studies on cellular responses in guinea pig macrophages, Journal of Immunology, 136, 3856, 10.4049/jimmunol.136.10.3856 Henderson, 1991, Inhibition of interleukin-1-induced synovitis and articular proteoglycan loss in the rabbit knee by recombinant human interleukin-1 receptor antagonist, Cytokine, 3, 246, 10.1016/1043-4666(91)90023-7 Hu, 1993, Disturbed immunoendocrine communication via the hypothalamo-pituitary-adrenal axis in autoimmune disease, International Archives of Allergy and Immunology, 102, 232, 10.1159/000236531 Inura, 1991, Cytokines and endocrine functions: an interaction between the immune and neuroendocrine systems, Clinical Endocrinology, 35, 107, 10.1111/j.1365-2265.1991.tb03506.x Jacob, 1989, Cytokines and anti-cytokines, Current Opinion in Immunology, 2, 249, 10.1016/0952-7915(89)90196-9 Jansky, 1992, A discrete mode of the anti-pyretic action of AVP, α-MSH and ACTH, Physiology Research, 41, 57 Jattela, 1991, Tumor necrosis factor as a potent inhibitor of adrenocorticotropin-induced cortisol production and steroidogenic P450 enzyme gene expression in cultured human fetal adrenal cells, Endocrinology, 128, 623, 10.1210/endo-128-1-623 Jessop, 1992, Substance P: multifunctional peptide in the hypothalamo-pituitary system?, Journal of Endocrinology, 132, 331, 10.1677/joe.0.1320331 Jiang, 1992, Monocyte chemoattractant protein-1 regulates adhesion molecule expresion and cytokine production in human monocytes, Journal of Immunology, 148, 2423, 10.4049/jimmunol.148.8.2423 Johnson, 1982, Vasopressin replacement of IL-2 requirement for IFNγ production: lymphokine activity of a neuroendocrine hormone, Journal of Immunology, 129, 983, 10.4049/jimmunol.129.3.983 Jorgensen, 1992, Molecular components of T cell recognition, Advances Reviews of Immunology, 10, 835, 10.1146/annurev.iy.10.040192.004155 June, 1990, Role of CD28 receptors in T cell activation, Immunology Today, 11, 211, 10.1016/0167-5699(90)90085-N Karalis, 1991, Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo, Science, 25, 421, 10.1126/science.1925600 Kashida, 1994, Corticotropin-releasing hormone enhances the superoxide anion production of rabbit peritoneal macrophages simulated with N-formyl-methionyl-leucyl-phenyalanine, Life Sciences, 34, 539, 10.1016/0024-3205(94)90004-3 Kasting, 1985, Endotoxin increases vasopressin release independently of known physiological stimuli, American Journal of Physiology, 248, E420 Kasting, 1982, Altered release of growth hormone and thyrotropin induced by endotoxin in the rat, American Journal of Physiology, 243, E332 Kidess, 1993, Transient corticotropin deficiency in critical illness, 68, 35 Kohler, 1967, Effect of pyrogen on blood levels of pituitary trophic hormones. Observations of the usefulness of the growth hormone response in the detection of pituitary disease, Journal of Clinical Endocrinology and Metabolism, 27, 219, 10.1210/jcem-27-2-219 Kovacs, 1991, Fibrogenic cytokines: the role of immune mediators in the development of scar tissue, Immunology Today, 12, 17, 10.1016/0167-5699(91)90107-5 Larsen, 1993, Substance P inhibits the release of anterior pituitary adreno-corticotrophin via a central mechanism involving corticotrophin-releasingfactor-containing neurons in the hypothalamic paraventricular nucleus, Journal of Neuroendocrinology, 5, 99, 10.1111/j.1365-2826.1993.tb00368.x Larsen, 1989, The neutrophil-activating protein (NAP-1) is also chemostactic for T lymphocytes, Science, 243, 1464, 10.1126/science.2648569 Leijon, 1994, Non-obese diabetic (NOD) mice display enhanced immune responses and prolonged survival of lymphoid cells, International Immunology, 6, 339, 10.1093/intimm/6.2.339 Lipton, 1990, modulation of the host responses by the neuropeptide αMSH, Yale Journal of Biology and Medicine, 63, 173 Lipton, 1992, αMSH peptides modulate fever and inflammation, 123 Lotz, 1987, Substance P activation of rheumatoid synoviocytes: neural pathway in pathogenesis of arthritis, Science, 235, 893, 10.1126/science.2433770 Lotz, 1988, Effect of neuropeptides on production of inflammatory cytokines by human monocytes, Science, 241, 1218, 10.1126/science.2457950 Mackay, 1993, Cell adhesion in the immune system, Immunology Today, 14, 99, 10.1016/0167-5699(93)90205-Y Mackiewicz, 1992, Complex of soluble human IL-6-receptor/IL-6 up-regulates expression of acute phase proteins, Journal of Immunology, 146, 2021, 10.4049/jimmunol.149.6.2021 1993, Acute Phase Proteins, Molecular Biology, Biochemistry and Clinical Applications Mapp, 1995, Neuropeptides and the synovium, 317 Marshall, 1990, Substance P and arthritis: analysis of plasma and synovial fluid levels, Arthritis and Rheumatism, 33, 87, 10.1002/art.1780330111 Mason, 1991, Genetic variation in the stress response: susceptibility to experimental allergic encephalomyelitis and implications for human inflammatory disease, Immunology Today, 12, 57, 10.1016/0167-5699(91)90158-P Mason, 1990, The role of neuroendocrine system in determining genetic susceptibility to experimental allergic encephalomyelitis in the rat, Immunology, 70, 1 Mason, 1989, Modulation of IL-1, TNF and C5α-mediated murine neutrophil migration by αMSH, Journal of Immunology, 142, 1646, 10.4049/jimmunol.142.5.1646 Mastorakos, 1993, Recombinant interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humans, Journal of Clinical Endocrinology and Metabolism, 77, 1690, 10.1210/jc.77.6.1690 Mastorakos, 1994, Hypothalamic-pituitary-adrenal axis activation and stimulation of systemic vasopressin secretion by recombinant interleukin 6 in humans: potential implications for the syndrome of inappropriate vasopressin secretion, Journal of Clinical Endocrinology and Metabolism, 79, 934, 10.1210/jc.79.4.934 Mathew, 1992, Vasoactive intestinal peptide stimulates the release of IL-5 in murine Schistosoma mansoni infection, Journal of Immunology, 148, 3572, 10.4049/jimmunol.148.11.3572 McInnes, 1995, Interleukin-15 in T cell migration and activation in rheumatoid arthritis, Arthritis and Rheumatism, 38, S235 Merenich, 1994, Hypothalamic and pituitary function in AIDS, Baillière's Clinical Endocrinology and Metabolism, 8, 757, 10.1016/S0950-351X(05)80298-8 Michie, 1988, Detection of circulating tumor necrosis factor after endotoxin administration, New England Journal of Medicine, 318, 1481, 10.1056/NEJM198806093182301 Moncada, 1991, NO: physiology, pathophysiology and pharmacology, Pharmacology, 43, 109 Morita, 1995, Anti-inflammatory properties of interleukin-13 in rheumatoid synovial inflammation, Arthritis and Rheumatism, 38, S353 Mosmann, 1986, Two types of murine helper T cell clone Definition according to profiles of lymphokine activities and secreted proteins, Journal of Immunology, 136, 2348, 10.4049/jimmunol.136.7.2348 Mugridge, 1991, αMSH reduces IL-1β effects on rat stomach preparations possibly through interference with IL-1 type 1 receptor, European Journal of Pharmacology, 197, 151, 10.1016/0014-2999(91)90514-Q Murphy, 1993, Differential effects of growth hormone and prolactin on murine T cell development and function, Journal of Experimental Medicine, 178, 231, 10.1084/jem.178.1.231 Navarra, 1991, Interleukins-1 and -6 stimulate the release of corticotropin releasing hormone-41 from rat hypothalamus in vitro via the eicosanoidcyclo-oxygenase pathway, Endocrinology, 128, 37, 10.1210/endo-128-1-37 Neeck, 1990, Adrenal secretion of cortisol in patients with rheumatoid arthritis, Journal of Rheumatology, 17, 24 Ohlsson, 1990, Interleukin-1 receptor antagonist reduces mortality from endotoxin shock, Nature, 348, 550, 10.1038/348550a0 Parker, 1985, Evidence for adrenocortical adaptation to severe illness, Journal of Clinical Endocrinology and Metabolism, 60, 947, 10.1210/jcem-60-5-947 Patchev, 1993, Increased arginine vasopressin secretion may participate in the enhanced susceptibility of Lewis rats to inflammatory disease, Neuroendocrinology, 58, 106, 10.1159/000126519 Patchev, 1992, Increased plasma concentrations, hypothalamic content, and in vitro release of arginine-vasopressin in inflammatory disease-prone, hypothalamicCRH-deficient Lewis rats, Endocrinology, 131, 1453, 10.1210/en.131.3.1453 Perlstein, 1993, Synergistic roles of interleukin-6, interleukin-1, and tumor necrosis factor in adreno-corticotropin response to bacterial lipopolysaccharide invivo, Endocrinology, 132, 946, 10.1210/en.132.3.946 Pinchot, 1949, Adrenal changes produced in rats by infection with B tularense and B. coli, Endocrinology, 45, 135, 10.1210/endo-45-2-135 Porat, 1993, Interleukin-1 receptor blockade reduces endotoxin and Borrelia burdoferi stimulated IL-8 synthesis in human mononuclear cells, FASEB Journal, 51, 1637 Rachmilewitz, 1993, Peroxynitrate induced rat colitis—a new model of colonic inflammation, Gastroenterology, 105, 1681, 10.1016/0016-5085(93)91063-N Reichlin, 1958, Thyroid function in experimental streptococcal pneumonia in the rat, Journal of Experimental medicine, 107, 219, 10.1084/jem.107.2.219 Reincke, 1994, Impairment of adrenocortical function with increase in plasma TNFα and IL-6 concentrations in African trypanosomiasis, Neuroimmunomodulation, 1, 14, 10.1159/000095930 Risdon, 1990, Mechanisms of chemoprevention by dietary DHEA: inhibition of lymphopoiesis, American Journal of Pathology, 136, 759 Rivier, 1989, In the rat, interleukin-1α acts at the level of the brain and the gonads to interfere with gonadotropin and sex steroid secretion, Endocrinology, 124, 2105, 10.1210/endo-124-5-2105 Roach, 1995, Opposing effects of interferon-γ on iNOS and interleukin-10 expression in LPS and mycobacterial lipoarabinomannan-stimulated macrophages, Immunology, 58, 106 Romagnani, 1991, Human Th1 and Th2 subsets: doubt no more, Immunology Today, 12, 256, 10.1016/0167-5699(91)90120-I Rook, 1994, Hormones, peripherally activated prohormones and regulation of the Th1/Th2/ balance, Immunology Today, 15, 301, 10.1016/0167-5699(94)90075-2 Rothwell, 1991, Cortisol responses to corticotropin and survival in septic shock, Lancet, 337, 582, 10.1016/0140-6736(91)91641-7 Sabharwal, 1992, Prolactin synthesized and secreted by human peripheral blood mononuclear cells: an autocrine growth factor for lymphoproliferation, 89, 7713 Salgame, 1991, Differing lymphokine profile of functional subsets of human CD4 and CD8 T cell clones, Science, 254, 279, 10.1126/science.1681588 Sapolsky, 1987, Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor, Science, 238, 522, 10.1126/science.2821621 scopa, 1994, Presence of immunoreactive corticotropin releasing hormone in thyroid lesions, American Journal of Pathology, 145, 1159 Seckinger, 1990, TNF inhibitor: purification, NH2 terminal amino acid sequence and evidence for anti-inflammatory and immunomodulatory activities, European Journal of Immunology, 20, 1167, 10.1002/eji.1830200533 1989, 245, 557 Singh, 1989, Stimulatory effects of corticotropin-releasing neurohormone on human lymphocyte proliferation and interleukin-2 receptor expression, Journal of Neuroimmunology, 23, 257, 10.1016/0165-5728(89)90058-1 Smith, 1991, Biologic effects of an interleukin-1 receptor antagonist protein on interleukin-1-stimulated cartilage erosion and chondrocyte responsiveness, Arthritis and Rheumatism, 34, 78, 10.1002/art.1780340112 Springer, 1990, Adhesion receptors of the immune system, Nature, 346, 425, 10.1038/346425a0 Stanisz, 1986, Differential effects of vasoactive intestinal peptide, substance P, and somatostatin on immunoglobulin synthesis and proliferations by lymphocytes from Peyer's patches, mesenteric lymph nodes, and spleen, Journal of Immunology, 136, 152, 10.4049/jimmunol.136.1.152 Stephanou, 1990, Corticotrophin-releasing factor-like immunoreactivity and mRNA in human leukocytes, Brain Behavioural Immunology, 4, 67, 10.1016/0889-1591(90)90007-D Sternberg, 1989, Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis susceptible Lewis rats, 86, 2374 Sundar, 1991, Human immunodeficiency virus gp 120 infused into rat brain induces IL-1 to elevate pituitary adrenal activity and decreases peripheral cellularimmune responses, 88, 11246 Suzuki, 1993, Serum soluble IL-6 receptor in MRL/1pr mice is elevated with age and mediates the IL-6 signal, European Journal of Immunology, 23, 1078, 10.1002/eji.1830230515 Taylor, 1993, Identification of αMSH as a potential immunosuppressive factor in aqueous humour, Current Eye Research, 11, 1199, 10.3109/02713689208999545 Tsagarakis, 1994, Cortiotrophin releasing hormone: Interactions with the immune system, Neuroimmunology, 1, 329 Tsagarakis, 1989, Interleukin-1 directly stimulates the release of corticotrophin releasing factor from rat hypothalamus, Neuroendocrinology, 49, 98, 10.1159/000125096 Udelsman, 1988, Hormonal responses to surgical stress, 265, 10.1007/978-1-4899-2064-5_21 Vamvakopoulos, 1993, Evidence of direct estrogenic regulation of human corticotropin-releasing hormone gene expression. Potential implications for the sexual dimorphismof the stress response and immune/inflammatory reaction, Journal of Clinical Investigatons, 92, 1896, 10.1172/JCI116782 Vankelecom, 1990, Interferon-γ inhibits stimulated adrenocorticotropin, prolactin, and growth hormone secretion in normal rat anterior pituitary cell cultures, Endocrinology, 126, 2919, 10.1210/endo-126-6-2919 Vinetti, 1994, Using inhibitors of metalloproteinases to treat arthritis, Arthritis and Rheumatis, 37, 1115, 10.1002/art.1780370802 Vita, 1995, Interleukin-15 increases the transendothelial migration of human T cells, Arthritis and Rheumatism, 38, S235 Wahl, 1988, Transforming growth factor β is a potent immunosupressive agent that inhibits IL-1 dependent lymphocyte proliferation, Journal of Immunology, 140, 3026, 10.4049/jimmunol.140.9.3026 Wick, 1993, The role of modulatory factors in the multifaceted pathogenesis of autoimmune thyroiditis, International Reviews of Immunology, 9, 77, 10.3109/08830189209061784 Wilder, 1993, Corticotropin releasing hormone and the hypothalamic-pituitary-adrenal axis in the regulation of inflammatory arthritis, Agents Actions, 41, 3 Woods, 1994, Association of human corticotropin-releasing hormone to its binding protein in blood may trigger clearance of the complex, Journal of Clinical Endocrinology and Metabolism, 78, 73, 10.1210/jc.78.1.73 Wooley, 1990, The effect of an interleukin-1 receptor antagonist protein on type 2 collagen and antigen-induced arthritis in mice, Arthritis and Rheumatism, 33, S20 Wu, 1991, Glucocorticosteroids suppress the production of IL-4 and Il-2 by human lymphocytes, European Journal of Immunology, 21, 2645, 10.1002/eji.1830211053 Yang-Yen, 1990, Transcriptional interference between c-jun and the glucocorticoid receptor: mutual inhibiton of DNA binding due to direct protein-protein interaction, Cell, 62, 1205, 10.1016/0092-8674(90)90396-V Yasin, 1993, Nitric oxide modulates the release of vasopressin from rat hypothalamic explants, Endocrinology, 133, 1466, 10.1210/en.133.3.1466 Yasin, 1994, Interleukin-1 and interleukin-6 stimulate neurohypophyseal hormone release in vitro, Journal of Neuroendocrinology, 6, 179, 10.1111/j.1365-2826.1994.tb00570.x Yssel, 1992, IL-10 is produced by subsets of human CD4+T cell clones and peripheral blood cells, Journal of Immunology, 149, 2378, 10.4049/jimmunol.149.7.2378